Published on LinkedIn via Spencer Knight The FDA has granted two approvals within 24 hours. Novartis’s Leqvio (inclisiran), a...

Published in Alliance for Regenerative Medicine (April 2025 Preview) A new whitepaper from the Alliance for Regenerative Medicine...

Published on Mass General Brigham After years of debilitating pain from sickle cell disease, Allan Byamukama became one of the first...

Published on LinkedIn via Spencer Knight AbbVie has secured worldwide rights to ISB 2001, a first-in-class trispecific antibody developed...

Published on LinkedIn via Spencer Knight GSK has entered a $12 billion licensing deal with China’s Hengrui Pharma, paying $500 million...

Published on Autolus Therapeutics News Releases Autolus’s CAR‑T therapy, AUCATZYL (obecabtagene autoleucel), has received marketing...

Published on Stanford Medicine News Stanford researchers have successfully used an antibody, briquilimab, to prepare children with...

A new paper in Cytotherapy describes an integrated platform that may significantly accelerate how CAR-T cells are produced. Researchers...

Published on LinkedIn via Laurie Adami Laurie Adami shared her 7-year remission milestone after receiving Yescarta CAR‑T therapy in a...

Published on NIH Research Matters NIH-funded researchers led by Capstan Therapeutics and the University of Pennsylvania have devised a...

Published on Fierce Biotech A recent Jefferies report reveals that in Q1 2025, China-based biotechs accounted for 32 percent of global...

Published in Journal of Translational Medicine A recent study explores how solid tumors alter CAR‑T cell lipid metabolism, affecting...

Published on LinkedIn via Spencer Knight AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics to deepen its investment...

Published on LinkedIn via Spencer Knight The FDA has updated CAR-T therapy regulations for BMS’ Abecma and Breyanzi, removing REMS...

Published on Independent UK / LinkedIn via Spencer Knight A three-year-old girl with a rare disorder called AADC deficiency has become...

Published on CAR T Vision (via CAR T Vision Coalition website) A new international coalition, CAR T Vision, has launched with a bold...

Published on The Associated Press Sarepta has suspended shipments of Elevidys and paused a trial arm after a second non-ambulatory...

Published on Spencer Knight via LinkedIn Eli Lilly has announced plans to acquire Verve Therapeutics in a deal worth up to $1.3 billion....

Published on Spencer Knight via LinkedIn Supernus Pharmaceuticals is acquiring Sage Therapeutics in a $795 million all-cash deal....

Published on Spencer Knight via LinkedIn BioNTech has signed a definitive agreement to acquire CureVac in an all-stock transaction valued...